Characterization of Subjects With Turner Syndrome Treated With Growth Hormone in the National Cooperative Growth Study (NCGS)

Genentech, Inc.0 个研究点目标入组 1,696 人开始时间: 1997年5月最近更新: 2012年11月14日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Genentech, Inc.
入组人数: 1,696

研究概览研究设计入排标准研究者记录与标识符相似试验

研究概览

简要总结

This study is a multicenter, open-label, observational, postmarketing surveillance study of Genentech growth hormone (GH) products in the treatment of girls with Turner syndrome in the United States and Canada.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Prospective

入排标准

年龄范围: — 至 17 Years（Child）
性别: Female
接受健康志愿者: 否

入选标准

•Are girls with Turner syndrome who are being or will be treated with Nutropin, Nutropin AQ, or Protropin
•Are willing to keep follow-up appointments throughout study participation
•Are girls with Turner syndrome who have submitted Form 4 upon discontinuation and may also submit Form 9

排除标准

•Have Noonan syndrome
•Subjects treated within the last 6 months with a non-Genentech GH preparation
•Have closed epiphyses prior to NCGS enrollment
•Have active neoplasia

研究者

发起方

Genentech, Inc.

申办方类型

Industry

责任方

Sponsor

相似试验

已完成

不适用

Turner Syndrome: Genotype and PhenotypeTurner's Syndrome

NCT00006334Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1,017

撤回

不适用

A genetic follow up study in Turner syndromepatients with 45Patients with Turner syndromeX.10083624

NL-OMON34852eids Universitair Medisch Centrum85

招募中

不适用

UTHealth Turner Syndrome Research RegistryTurner Syndrome

NCT03185702The University of Texas Health Science Center, Houston200

招募中

不适用

Turner syndrome minipuberty studyTurner syndrome

NL-OMON54918Radboud Universitair Medisch Centrum30

已完成

2 期

Hormone Replacement Therapy to Treat Turner SyndromeTurner's SyndromeOsteoporosis

NCT00013546Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)92